Skip to content

Comparing dementia diagnostics in primary care and in memory clinics: which makes older patients fare better in the long term?

Primary care diagnostics or diagnostics in a memory clinic in older persons with memory complaints: a long-term cost-effectiveness trial with a non-inferiority design

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18043557
Enrollment
182
Registered
2023-03-15
Start date
2023-07-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persons aged 70 years and older with memory complaints Mental and Behavioural Disorders

Interventions

Current interventions as of 13/07/2023: Intervention: For the primary care arm, the diagnostic procedures are described in the Dementia Guideline of the Dutch College of General Practitioners. The mi

Sponsors

Radboud University Nijmegen Medical Centre
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients 70 years and older consulting the GP with memory problems are eligible if the patient and GP consider starting diagnostic evaluation

Exclusion criteria

Exclusion criteria: 1. Patients are excluded if referral is clearly indicated due to suspicion of an uncommon form of dementia or another brain disease with accompanying memory problems, based on history or focal signs on neurological examination, such as extrapyramidal signs, hemiparesis or Babinski’s sign 2. Patients are also excluded if the GP considers referral undesirable, e.g. in case of concomitant terminal illness (added 20/11/2024) If patients do not want to be randomized, they are invited to participate in the prospective cohort study.

Design outcomes

Primary

MeasureTime frame
Current primary outcome measures as of 22/10/2025: Daily functioning measured using the Amsterdam Instrumental Activities of Daily Living Questionnaire Short Version (A-iADL-Q-SV). Both primary and secondary outcomes are measured at baseline, 6 months, 18 months and 24 months (four time points including baseline) or until attrition due to death, because the relatively short diagnostic trajectories are likely to have long-term consequences due to disease management decisions following diagnosis. _____ Previous primary outcome measure as of 20/11/2024: Daily functioning measured using the Amsterdam Instrumental Activities of Daily Living Questionnaire Short Version (A-iADL-Q-SV). Both primary and secondary outcomes are measured at baseline, 6 months, 18 months and (24-)30 months (four time points including baseline) or until attrition due to death, because the relatively short diagnostic trajectories are likely to have long-term consequences due to disease management decisions following diagnosis. In case of institutionalization, primary outcome assessment continues, other outcomes if feasible and appropriate. _____ Previous primary outcome measure as of 13/07/2023: Daily functioning measured using the Amsterdam Instrumental Activities of Daily Living Questionnaire Short Version (A-iADL-Q-SV). Both primary and secondary outcomes are measured at baseline, 6 months, 18 months and 30 months (four time points including baseline) or until attrition due to death, because the relatively short diagnostic trajectories are likely to have long-term consequences due to disease management decisions following diagnosis. In case of institutionalization, primary outcome assessment continues, other outcomes if feasible and appropriate. _____ Previous primary outcome measure: Daily functioning measured using the Amsterdam Instrumental Activities of Daily Living Questionnaire (A-iADL-Q). Both primary and secondary outcomes are measured at baseline, 6 months, 18 months and 30

Secondary

MeasureTime frame
Current secondary outcome measures as of 22/10/2025: 1. Diagnostic accuracy, measured using the first dementia diagnosis as the index diagnosis and the diagnosis at 24 months as the reference standard. 2. Time to dementia diagnosis assessed based on information available in electronic medical records 3. Acute admissions and time to institutionalization (months): information available in electronic medical records 4. (Time to) mortality reported by caregiver or general practitioner 5. Quality of life measured using EQ-5D 6. Costs measured using Resource Utilization in Dementia (RUD) 7. Cognition measured using the short cognitive screening test Mini-Mental State Examination (MMSE) 8. Behavior measured using the Neuro-Psychiatric Inventory Questionnaire (NPI-Q) 9. Mood measured using the Geriatric Depression Scale (GDS-15) 10. Caregiver burden measured using perseverance time Both primary and secondary outcomes are measured at baseline, 6 months, 18 months and 24 months (four time points including baseline) or until attrition due to death, because the relatively short diagnostic trajectories are likely to have long-term consequences due to disease management decisions following diagnosis. A short questionnaire will be administered to caregivers who decline to complete the A-IADL-Q-SV at follow-up. It collects a minimal dataset on mortality, changes in residence, and hospital admissions/ER visits, using questions from the RUD _____ Previous secondary outcome measures as of 20/11/2024: 1. Diagnostic accuracy, measured using the first dementia diagnosis as the index diagnosis and the diagnosis at 30 months as the reference standard. Dementia diagnosis will be assessed using an algorithmic approach, with all clinical information available in electronic medical records. 2. Time to dementia diagnosis assessed based on information available in electronic medical records 3. Acute admissions and time to institutionalization (months): information available in electron

Countries

Netherlands

Contacts

Public ContactDemi Ronner
demi.ronner@radboudumc.nl+31 (0)243698735

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026